From: The association between oxidized low-density lipoprotein antibodies and hematological diseases
Serial number + group | CTH | TG | APD | HDL-C | LDL-C | oxLDL | oxLDL-IgG | oxLDL-IgM |
---|---|---|---|---|---|---|---|---|
①cases with non lymphatic leukemia | 4.00 ± 1.018 | 1.64 ± 1.055 | 7.56 ± 9.976 | 0.68 ± 0.355 | 2.97 ± 0.991 | 31.48 ± 21.594 | 38.57 ± 19.483 | 18.70 ± 10.510 |
② cases with lymphatic leukemia | 3.90 ± 1.358 | 1.44 ± 0.910 | 2.40 ± 1.089 | 1.14 ± 0.834 | 2.47 ± 1.158 | 21.76 ± 10.846 | 28.14 ± 19.185 | 20.24 ± 9.915 |
③ cases with Hemolytic anemia | 3.07 ± 0.805 | 1.62 ± 1.352 | 6.58 ± 8.409 | 0.92 ± 0.481 | 2.13 ± 1.079 | 21.08 ± 9.871 | 31.98 ± 20.364 | 23.89 ± 9.081 |
④ cases with immunothrombocytopenia | 4.50 ± 0.866 | 1.24 ± 0.419 | 4.59 ± 6.395 | 0.96 ± 0.956 | 3.28 ± 1.047 | 17.33 ± 4.716 | 45.96 ± 25.804 | 17.74 ± 9.512 |
⑤ cases with multiple myeloma | 4.13 ± 1.829 | 1.60 ± 0.903 | 5.08 ± 7.687 | 0.44 ± 0.312 | 3.51 ± 1.526 | 25.39 ± 12.593 | 61.82 ± 33.245 | 17.97 ± 6.918 |
⑥ cases with non Kochkin’s | 5.50 ± 1.273 | 2.16 ± 1.062 | 5.49 ± 8.018 | 1.24 ± 1.141 | 3.82 ± 1.073 | 24.47 ± 18.673 | 38.25 ± 19.241 | 21.58 ± 14.194 |
⑦ cases with myelodysplastic syndrome | 3.83 ± 0.854 | 1.19 ± 0.352 | 14.25 ± 12.550 | 0.70 ± 0.799 | 2.89 ± 0.427 | 52.68 ± 33.884 | 21.93 ± 10.368 | 23.17 ± 12.745 |
⑧ patients with primary hypertension | 5.78 ± 1.2223 | 1.58 ± 0.952 | 5.57 ± 7.457 | 1.04 ± 0.560 | 4.43 ± 1.401 | 25.83 ± 10.735 | 82.18 ± 10.117 | 10.31 ± 9.130 |
⑨ healthy normal persons | 5.09 ± 0.568 | 1.35 ± 1.167 | 3.28 ± 4.068 | 1.52 ± 1.169 | 3.36 ± 1.281 | 38.91 ± 15.514 | 77.59 ± 7.165 | 8.82 ± 9.685 |
F | 42.104 | 5.424 | 11.225 | 12.234 | 24.532 | 24.963 | 100.115 | 17.313 |
P | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |